Peer-influenced content. Sources you trust. No registration required. This is HCN.
Epoch Health
Less than half of people prescribed gabapentin will not notice meaningful pain relief but will likely experience side effects or adverse events.
Family Medicine/General Practice November 18th 2025
Multiple oncologists report anecdotal success with antiparasitic protocols, citing at least 12 potential anticancer mechanisms while acknowledging the absence of human clinical trials and FDA approval for cancer treatment.
Hematology/Oncology July 22nd 2025
Oncology News Central (ONC)
Nearly 20 million viewers watched content suggesting antiparasitic drugs cured stage IV cancer, prompting widespread patient inquiries despite absence of human efficacy data.
Oncology, Medical July 22nd 2025
Verywell Mind
Clinical trials demonstrate bupropion effectiveness at 150-450mg daily for ADHD symptom reduction, with extended-release formulations improving medication adherence through once-daily dosing.
Family Medicine/General Practice June 17th 2025
Medical News Today (MNT)
Claims that semaglutide microdosing works to maintain weight loss and manage blood sugar are mainly anecdotal and not backed by scientific research.
Clinical Pharmacology April 9th 2025
Cleveland Clinic Journal of Medicine (CCJM)
In the absence of contraindications, metformin should be seriously considered as an off-label initial therapy and as an adjunct to antiobesity medications approved by the US Food and Drug Administration.
Endocrinology, Diabetes, Metabolism April 2nd 2025
DIET & NUTRITION 
PATIENT EDUCATION 
OBESITY/WEIGHT MANAGEMENT 
EXERCISE/TRAINING 
LEGAL MATTERS 
GUIDELINES/RECOMMENDATIONS